John Saia | General Counsel |
Vince Angotti | CEO |
Dr. Pam Palmer | Chief Medical Officer |
Kimberley Gaumer | VP, Regulatory Affairs and Quality |
Raffi Asadorian | CFO |
Randall Stanicky | RBC Capital Markets |
Ed Arce | H.C. Wainwright & Co. |
Brandon Folkes | Cantor Fitzgerald |
Michael Higgins | Ladenburg Thalmann |
David Buck | B.Riley FBR |
Leland Gershell | Oppenheimer and Company |
Welcome to the DSUVIA FDA Approval and AcelRx Third Quarter 2018 Conference Call. This call is being webcast live on the Events page of the Investors section of AcelRx’s website at acelrx.com. This call is the property of AcelRx and any recording, reproduction or transmission of this call without the express written consent of AcelRx is strictly prohibited.
As a reminder, today’s call is being recorded.
You may listen to a webcast replay of this call by going to the Investors section of AcelRx’s website.